Research
Global Crown Capital is committed to producing the highest-quality proprietary research coverage to help investors make informed decisions in this complex field. GCC publishes the only systematic research of public nanotech equities worldwide.
This means Global Crown Capital has:
- Unique insight into research pipelines, competing technologies, intellectual property status, commercialization progress and the status of various business models in the nanotech industry.
- Highly sophisticated analyses, including fundamental and technical analyses, providing a guide for stock selection, as well as position entry and exit points.
- Research covering entire value chains – this is important because nano-materials and devices are part of a vertically integrated chain with multiple buying groups and various stages of approval.
- A unique perspective on timing. This is essential to GCC's forecasting expertise, to determine which sub-sectors and which companies within the nanotech industry have the most foreseeable commercialization potential.
Our analysts and advisors serve as an ideal team for de-mystifying nanotech and critically evaluating investment opportunities. Our analysts will provide fundamental research coverage on all leading industries impacted by nanotech, including Materials, Equipment, Semiconductors, Software, Healthcare, Biotech, Medical Devices and Energy.